Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Concurrent chemoradiotherapy for advanced cervical cancer--a pilot study].

J Kodama1, I Hashimoto, N Seki

  • 1Dept. of Obstetrics and Gynecology, Okayama University Medical School.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 27, 2001
PubMed
Summary

Concurrent chemoradiotherapy with carboplatin or nedaplatin shows promise for locally advanced cervical cancer. This combination therapy was found to be safe and well-tolerated, with minimal toxicity, suggesting its potential as a radiation sensitizer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coping strategies and risk of cardiovascular disease incidence and mortality: the Japan Public Health Center-based prospective Study.

European heart journal·2016
Same author

Development of a psoriasis-like syndrome following lithium therapy.

Biological trace element research·2013
Same author

Role of aquaporin-5 in gallbladder carcinoma.

European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes·2013
Same author

Stage IB1 cervical cancer patients with an MRI-measured tumor size < or = 2 cm might be candidates for less-radical surgery.

European journal of gynaecological oncology·2013
Same author

Short communication: effect of difructose anhydride III on serum immunoglobulin G concentration in newborn calves.

Journal of dairy science·2012
Same author

A study of Atopic dermatitis in elementary school children in Hirosaki city, Aomori prefecture, Japan.

Environmental health and preventive medicine·2011

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Oncology

Context:

  • Cervical cancer is a significant global health concern, particularly in its locally advanced stages.
  • Conventional treatments like radiotherapy and chemotherapy have limitations, necessitating novel therapeutic strategies.
  • Combining radiotherapy with chemotherapy agents like carboplatin or nedaplatin is an area of active research for solid tumors.

Purpose:

  • To evaluate the safety and efficacy of concurrent chemoradiotherapy using carboplatin or nedaplatin in patients with locally advanced cervical cancer.
  • To assess the toxicity profile, including renal, hematological, and gastrointestinal adverse events.
  • To determine the potential of these platinum-based agents as radiation sensitizers in this patient population.

Summary:

Related Experiment Videos

  • A pilot study treated 24 patients with locally advanced cervical cancer using conventional radiotherapy combined with either daily carboplatin or weekly nedaplatin.
  • Among 13 evaluable patients, a high response rate was observed: nine complete responders and four partial responders.
  • The treatment regimen demonstrated a favorable safety profile, with no renal damage or grade 4 hematological toxicity, and mild gastrointestinal side effects.

Impact:

  • This study suggests that concurrent carboplatin or nedaplatin with radiotherapy is a safe and well-tolerated treatment option.
  • The findings indicate that these platinum-based agents may serve as effective radiation sensitizers, potentially improving outcomes for locally advanced cervical cancer.
  • Further investigation is warranted to confirm these results in larger clinical trials.